Nerve block may cut opioid use after robotic colorectal surgery
NCT ID NCT07185607
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tested whether a nerve block called the erector spinae plane block (ESPB) can reduce pain and the need for opioids after robotic colorectal surgery. 70 patients with colorectal cancer were enrolled. The block is a simple ultrasound-guided injection near the spine. Researchers measured pain scores and total opioid use in the first 24 hours after surgery.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Erector spinae plane block (ESPB) - a regional anesthesia procedure
- What this could lead to
- If effective, this nerve block could become a standard way to manage pain after robotic colorectal surgery, reducing opioid use and speeding recovery.
- What could go wrong
- This is a small, single-center study with no blinding or placebo control. Results may not apply to all patients or surgeries, and the block carries rare risks like bleeding or infection.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
70 people
The number who actually took part.
- Started
-
Jan 2024
- Finished
-
Sep 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 75 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * ASA I-III * Male and female gender * Ages 18-75 * Malignant patients undergoing robotic colorectal surgery Exclusion Criteria: * ASA\>III * Coagulopathy * Morbid obesity * History of chronic analgesic use * Data loss due to limited cooperation during NRS follow-up
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Colorectal cancer are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Basaksehir Cam ve Sakura City Hospital
Istanbul, 34480, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Gut bacteria may hold clues to why some cancer treatments work better
- Burning the edges: a new way to stop colon polyps from coming back
- Missed Follow-Up colonoscopies: do they raise the risk of advanced growths?
- A nerve block that spares arm movement tested for shoulder surgery pain
- Could a nerve block replace opioids for severe belly pain in the ER?
- A 2.2 mm scope could spot cancerous tissue in minutes, not days